Neuropathies associated with excessive exposure to lead

Muscle and Nerve

Volumn 33, Issue 6, 2006, Pages 732-741

  Thomson, Ruth M ^a   Parry, Gareth J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Axonal degeneration; Heme synthesis; Lead neuropathy; Occupational neuropathy; Porphyrins; Toxic neuropathy

Indexed keywords

EDETIC ACID; LEAD; PENICILLAMINE; PORPHYRIN; SUCCIMER;

CHELATION THERAPY; CLINICAL TRIAL; DEMYELINATING NEUROPATHY; DRUG DOSE REGIMEN; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL MONITORING; EXTENSOR MUSCLE; FINGER; HEME SYNTHESIS; HUMAN; INDUSTRIAL HYGIENE; LEAD BLOOD LEVEL; LEAD NEUROPATHY; LEAD POISONING; LIVER TOXICITY; LONG TERM EXPOSURE; MUSCLE WEAKNESS; NEPHROTOXICITY; NERVE FIBER DEGENERATION; NEUROPATHY; NONHUMAN; OCCUPATIONAL EXPOSURE; PORPHYRIN METABOLISM; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK REDUCTION; SENSORIMOTOR NEUROPATHY; WRIST;

ANIMALS; ENVIRONMENTAL EXPOSURE; HUMANS; LEAD POISONING, NERVOUS SYSTEM, ADULT; OCCUPATIONAL DISEASES;

EID: 33745002716     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20510     Document Type: Review

References (43)

1. Araki S, Honma T, Yanagihara S, Ushio K. Recovery of slowed nerve conduction velocity in lead-exposed workers. Int Arch Occup Environ Health 1980;46:151-157.
2. Ashby JAS. A neurological and biochemical study of early lead poisoning. Br J Ind Med 1980;37:133-140.
3. Aub JC, Fairhall LT, Minot AS, Reznikoff P. Lead poisoning. Medicine 1925;4:1-250.
4. Behse F, Carlson F. Histology and ultrastructure of alterations in neuropathy. Muscle Nerve 1978;1:368-374.
5. Buchthal F, Behse F. Electrophysiology and nerve biopsy in men exposed to lead. Br J Indust Med 1979;36:135-142.
6. Campbell AMG, Williams ER, Barltrop D. Motor neurone disease and exposure to lead. J Neurol Neurosurg Psychiatry 1970;33:877-881.
7. Cantarow A, Trumper M. Lead poisoning. Baltimore: Williams & Wilkins; 1944.
8. Catton MJ, Harrison MJG, Fullerton PM, Kazantzis G. Sub-clinical neuropathy in lead workers. Br Med J 1970;2:80-82.
9. Chuang HY, Tsai SY, Choa KY, Lian CY, Yang CYi, Ho CK, et al. The influence of milk intake on lead toxicity to sensory nervous system in lead workers. Neurotoxicity 2004;25:941-949.
10. Coyle P, Kosnett MJ, Hipkins K. Severe lead poisoning in the plastics industry: a report of three cases. Am J Indust Med 2005;47:172-175.
11. Cullen MR, JM Robin JM, Eskenazi B. Adult inorganic lead intoxication: presentation of 31 new cases and a review of recent advances in the literature. Medicine 1980;62:221-247.
12. Dyer J, Garrick DP, Inglis A, Pye IF. Plumboporphyria (ALAD deficiency) in a lead worker: a scenario for potential diagnostic confusion. Br J Indust Med 1993;50:1119-1121.
13. Ehle AL. Lead neuropathy and electrophysiological studies in low level lead exposure: a critical review. Neurotoxicology 1986;7:203-216.
14. Emmerson BT. Chronic lead neuropathy: the diagnostic use of calcium-EDTA and the association with gout. Aust Ann Med 1963;12:310-313.
15. Environmental Protection Agency: www.epa.gov.
16. Gombault M. Contribution a l'etude anatomique de la nevrite parenchymateuse subaigue et chronique - nevrite segmentaire peri-axile. Arch Neurol (Paris). 1880;1:11-38.
17. Goyer RA, Rhyne BC. Pathological effects of lead. Int Rev Exp Pathol 1973;12:1-77.
18. Guidetti D, Bondavalli M, Sabadini R, Marcello N, et al. Epidemiological survey of amyotrophic lateral sclerosis in the province of Reggio Emilia, Italy: influence of environmental exposure to lead. Neuroepidemiology 1996;15:301-312.
19. Hopkins A. Experimental lead poisoning in the baboon. Br J Indust Med 1970;27:130-140.
20. Kosnett, MJ. Unanswered questions in metal chelation. J Toxicol Clin Toxicol 1992;30:529-547.
21. Krigman MR, Bouldin TW, Mushak P. Lead. In: Spencer PS, Schaumburg HH, editors. Experimental and clinical neurotoxicology. Baltimore: Williams & Wilkins; 1980. p 490-507.
22. Landrigan PJ, Lioy PJ, Thurston G, Berkowitz G, Chen LC, Chillrud SN, et al. (NIEHS World Trade Center Working Group). Health and environmental consequences of the World Trade Center disaster. Environ Health Perspect 2004;112:731-739.
23. Lioy PJ, Weisel CP, Millette JR, Eisenreich S, Vallero D, Offenberg J, et al. Characterization of the dust/smoke aerosol that settled east of the World Trade Center in lower Manhattan after the collapse of the WTC 11 September 2001. Environ Health Perspect 2004;110:703-714.
24. Linden MA, Manton WI, Stewart RM, Thal ER, Feit H. Lead poisoning from retained bullets. Pathogenesis, diagnosis and management. Ann Surg 1982;195:305-313.
25. Marcus SM. Experience with D-penicillamine in treating lead poisoning. Vet Hum Toxicol 1982;24:18-20.
26. Mitchell CS, Shear MS, Bolla KI, Schwartz BS. Clinical evaluation of 58 organolead manufacturing workers. J Occup Environ Med 1996;38:372-378.
27. National Institute of Occupational Safety and Health: www. cdc.gov/niosh.
28. Occupational Safety and Health Administration: www.osha. gov.
29. Oh SJ. Lead neuropathy: case report. Arch Phys Med Rehabil 1975;56:312-317.
30. Ohnishi A, Schilling K, Brimijoin WS, Lambert EH, Fairbanks VG, Dyck PJ. Morphometry, nerve conduction, and choline acetyltransferase transport; new finding of edema associated with segmental demyelination. J Neuropathol Exp Neurol 1977;36:499-518.
31. Paulev PE, Gry C, Dossing M. Motor nerve conduction velocity in asymptomatic lead workers. Int Arch Occup Environ Health 1979;43:37-43.
32. Patton L, Smith DR, Strupp BJ. Evaluation of succimer chelation in removing lead from brain, bone, kidney and blood: effects of treatment duration and body lead burden. Neurotoxicol Teratol 1998;20:363.
33. Rosenman KD, Sims A, Luo Z, Gardiner J. Occurrence of lead-related symptoms below the current Occupational Safety and Health Act allowable lead levels. J. Occup Environ Med 2003;45:546-555.
34. Rubens O, Logina I, Kravale I, Eglite M, Donaghy M. Peripheral neuropathy in chronic occupational inorganic lead exposure: a clinical and electrophysiological study. J Neurol Neurosurg Psychiatry 2001;71:200-204.
35. Ryan RP, Terry CE. Lead. In: Toxicology desk reference. Philadelphia: Taylor and Francis; 1999. p 759-802.
36. Seppalainen AM, Tola S, Hernberg S, Kock B. Subclinical neuropathy at "safe" levels of lead exposure. Arch Environ Health 1975;30:180-183.
37. Seppalainen AM, Hernberg S, Kock B. Relationship between blood lead levels and nerve conduction studies. Neurotoxicology 1979;1:313-332.
38. Seto DSY, Freeman JM. Lead neuropathy in childhood. Am J Dis Child 1964;107:337-342.
39. Simpson JA, Seaton DA, Adams JF. Response to treatment with chelating agents of anemia, chronic encephalopathy and myelopathy due to lead poisoning. J Neurol Neurosurg Psychiatry 1964;27:536-541.
40. Windebank AJ. Metal neuropathy. In: Dyck PJ, Thomas PE, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. Philadelphia: WB Saunders; 1993. p 1549-1570.
41. Windebank AJ. Heavy metals and neurological disease. In: Evans RW, Baskin DS, Yatsu FM, editors. Prognosis of neurological disorders. New York: Oxford University Press; 1992. p 571-576.
42. Wu PBJ, Kingery WS, Date ES. An EMG case report of lead neuropathy 19 years after a shotgun injury. Muscle Nerve 1995;18:326-329.
43. Zenz C. Occupational medicine: principles and practical applications. St Louis: Mosby Yearbook; 1988. p 563.